FindTrial
Sign In

Analgesic efficacy of adjuvant nefopam on patient controlled analgesia in patients undergoing laparoscopic colorectal cancer surgery

Analgesic efficacy of adjuvant nefopam on patient controlled analgesia in patients undergoing laparoscopic colorectal cancer surgery

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0005037
Enrollment
200
Registered
2020-05-19
Start date
2020-05-07
Completion date
Unknown
Last updated
2020-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Samsung Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: patients with colorectal cancer who underwent laparoscopic colorectal surgery from January 2015 to April 2020

Exclusion criteria

Exclusion criteria: emergent surgery, metastatic colorectal lesions, conversion to open surgery, the need for intensive care unit management after surgery, inability to express pain severity, patients who were taken non-opioid analgesics during anesthesia, and patients with nefopam contraindications

Design outcomes

Primary

MeasureTime frame
postoperative pain score—

Secondary

MeasureTime frame
postoperative analgesic dose—

Countries

Korea, Republic of

Contacts

Public ContactJin Young Lee

Samsung Medical Center

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026